How inhibiting one protein could provide the key in the treatment of Parkinson’s disease

Researchers from Georgetown University Medical Center (DC, USA) have found the protein – USP13 – removes all the tags on the protein alpha-synuclein which would normally mark them for destruction and leads to accumulation of the protein in a cluster which has toxic effects in the brain.